Molecular Pain
Scope & Guideline
Exploring the molecular mechanisms of pain.
Introduction
Aims and Scopes
- Molecular Mechanisms of Pain:
Research on the biochemical and molecular pathways involved in pain perception, including studies on receptors, ion channels, and signaling pathways that mediate nociception. - Neuroinflammation and Pain:
Exploration of the role of neuroinflammatory processes in the development and maintenance of chronic pain states, including the interactions between immune cells and the nervous system. - Analgesic Drug Development:
Studies aimed at discovering and characterizing new analgesics, including pharmacological evaluations of existing medications and novel compounds targeting pain pathways. - Genetic and Epigenetic Factors in Pain:
Investigation of genetic predispositions and epigenetic modifications that influence pain sensitivity and chronic pain conditions. - Clinical Pain Research:
Clinical studies and trials assessing pain management strategies, patient outcomes, and the efficacy of various treatment modalities in different pain conditions. - Pain Models and Experimental Approaches:
Development and application of animal models to study pain mechanisms and test potential therapeutic interventions.
Trending and Emerging
- Neuroimmune Interactions in Pain:
An increasing number of studies focus on the interactions between the nervous system and immune cells, highlighting the role of neuroinflammation and immune signaling in the pathophysiology of chronic pain. - Microbiome and Pain:
Emerging research explores the relationship between gut microbiota and pain, suggesting that microbial composition may influence pain sensitivity and chronic pain conditions. - Personalized Pain Management:
There is a growing emphasis on personalized medicine approaches in pain management, including genetic profiling and tailored therapies based on individual patient characteristics. - Advancements in Pain Biomarkers:
Research is increasingly directed towards identifying biomarkers for pain assessment and management, facilitating early diagnosis and personalized treatment strategies. - Regenerative and Novel Therapies:
An emerging focus on regenerative medicine and novel therapeutic approaches, such as gene therapy and biologics, is reflected in recent studies aimed at treating pain more effectively.
Declining or Waning
- Traditional Analgesics Research:
Research focusing primarily on traditional analgesics, such as opioids, has seen a decrease, possibly due to increased scrutiny of opioid use, leading to a shift towards exploring alternative therapies and mechanisms. - Basic Pain Sensation Studies:
Studies that focus solely on basic sensory mechanisms of pain without integrating molecular or therapeutic aspects appear to be waning, as the field increasingly emphasizes translational research. - Purely Behavioral Pain Assessments:
Research that relies solely on behavioral assessments of pain without molecular or mechanistic insights is becoming less common, indicating a trend towards more integrative and mechanistic studies. - Chronic Pain Epidemiology Studies:
While still relevant, the volume of epidemiological studies on chronic pain prevalence and risk factors has decreased, suggesting a potential shift towards more mechanistic and intervention-focused research.
Similar Journals
Pain and Therapy
Elevating Understanding in Pain and Neurology.Pain and Therapy is a prestigious, peer-reviewed journal published by SPRINGER INTERNATIONAL PUBLISHING AG that has been a beacon of research in the field of pain management and neurology since its inception in 2012. With an ISSN of 2193-8237 and an E-ISSN of 2193-651X, this open access journal facilitates the dissemination of high-quality research to a global audience. Recognized within the top Q1 quartile for Anesthesiology and Pain Medicine, and the Q2 category for Clinical Neurology, it ranks impressively within the Scopus indexing, positioned at #20/136 in its primary category, demonstrating an 85th percentile standing. The journal's commitment to open access enhances its impact, allowing researchers, clinicians, and students to explore and contribute to critical developments in pain therapy and management. The convergence of cutting-edge research and innovative therapeutic strategies makes Pain and Therapy an essential resource for anyone dedicated to advancing knowledge in this vital field.
Journal of Endometriosis and Pelvic Pain Disorders
Connecting researchers and practitioners for better outcomes.Journal of Endometriosis and Pelvic Pain Disorders, published by SAGE Publications Ltd, is a vital resource dedicated to advancing the understanding and management of endometriosis and associated pelvic pain disorders. With an ISSN of 2284-0265 and E-ISSN 2284-0273, this journal caters to a diverse audience of researchers, healthcare professionals, and students in the field of Obstetrics and Gynecology. It has a notable 2023 Scopus ranking of #139 out of 209 in its category, positioning it within the Q3 quartile based on its impact and contribution to the literature. The journal aims to publish cutting-edge research, reviews, and clinical guidelines that illuminate the complexities of endometriosis and enhance patient care. Available through various academic channels, it not only fosters scholarly discourse but also supports the academic community in addressing the challenges and advancements in the treatment of pelvic pain disorders. As the journal approaches its converged years from 2013 to 2024, it stands as a critical platform for disseminating impactful findings in a field that significantly affects women’s health globally.
PAIN MEDICINE
Innovative Insights for Effective Pain ReliefPAIN MEDICINE, published by Oxford University Press, is a leading journal in the disciplines of Anesthesiology and Pain Medicine. With its ISSN 1526-2375 and E-ISSN 1526-4637, this esteemed journal provides a platform for innovative research and clinical advancements in the field of pain management. With an impressive impact factor attributed to its Q1 ranking in both Anesthesiology and Pain Medicine as well as Q2 in Clinical Neurology for 2023, PAIN MEDICINE ensures high visibility and relevance within the scientific community, noted for its diverse contributions from across the globe. The journal's editorial mission focuses on disseminating significant findings that influence contemporary practices and policies in pain management. Scholars and practitioners are encouraged to engage with this vital resource, which shapes the future of pain medicine from its base at Great Clarendon St, Oxford, England, covering a remarkable timeline from 2000 to 2024.
Journal of Pain Research
Advancing Pain Management Through Innovative ResearchJournal of Pain Research, published by DOVE MEDICAL PRESS LTD, stands at the forefront of the field of pain management and anesthesia, offering a critical platform for researchers and clinicians dedicated to advancing the understanding of pain and its treatment. With an Open Access model since 2008, this journal enhances accessibility to high-quality research, enabling a global audience to engage with innovative studies and findings. Recognized for its significant contributions, it has achieved a Q2 rank in Anesthesiology and Pain Medicine as of 2023, placing it among the top 30% in its category, and it holds a commendable Scopus rank of 41/136 in its field. Covering a broad scope encompassing clinical trials, pharmacology, and psychosocial aspects of pain, the journal invites submissions that advance both theoretical knowledge and practical applications, making it an invaluable resource for professionals, researchers, and students aiming to improve outcomes in pain management.
JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY
Elevating Standards in Pain and Palliative Care Pharmacotherapy.JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, published by Taylor & Francis Inc, is a vital resource for professionals in the fields of anesthesiology, pain medicine, and pharmacology. With an ISSN of 1536-0288 and an E-ISSN of 1536-0539, this esteemed journal has been providing a platform for innovative research and critical reviews since its inception in 2002, and it will continue to contribute to scientific discourse until 2024. Holding a Q2 ranking in Anesthesiology and Pain Medicine and a Q3 ranking in Medical Pharmacology, the journal is positioned to deliver high-impact articles that explore advancements in pain management and palliative care strategies. While not an Open Access journal, it offers significant subscription-based access to its curated content, ensuring that researchers and practitioners have the opportunity to stay updated on the latest trends and findings in pain therapy. Furthermore, with its Scopus rankings reflecting ongoing relevance and a robust academic community, this journal is essential for those aiming to deepen their understanding of pain management pharmacotherapy.
SCHMERZ
Connecting Practitioners with Cutting-Edge ResearchSCHMERZ is a pivotal journal in the fields of anesthesiology, pain medicine, and clinical neurology, published by SPRINGER HEIDELBERG in Germany. With an ISSN of 0932-433X and an E-ISSN of 1432-2129, the journal is celebrated for its rigorous peer-reviewed articles contributing to the understanding and management of pain. Since its inception in 1987, SCHMERZ has developed an impressive readership, ranking in the Q3 category across multiple disciplines, including Anesthesiology and Pain Medicine, and Clinical Neurology. Operating within the 50th percentile for anesthesiology and the 32nd percentile in neurology, the journal stands as a critical resource for practitioners, researchers, and students engaging with current trends and advancements in pain research and treatment. While not currently offering open access options, SCHMERZ continues to strive toward disseminating high-quality research and fostering vital discussions in the management of pain. With a scope that aims to bridge clinical practices with scientific understanding, SCHMERZ invites contributions that will illuminate and advance the multifaceted nature of pain and its treatment.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Innovating Therapeutic Strategies for a Healthier TomorrowThe JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, published by the American Society for Pharmacology and Experimental Therapeutics, stands as a pivotal platform in the fields of pharmacology and molecular medicine. With an impressive convergence of knowledge from 1945 to 2024, this esteemed journal is recognized for its rigorous peer-reviewed research, contributing significantly to our understanding of drug action and therapeutic interventions. It holds a commendable position in the Q2 quartile in both Molecular Medicine and Pharmacology, emphasizing its relevance and impact within the contemporary scientific landscape, as evidenced by its Scopus ranking that places it amongst the leading journals in its category. Aimed at researchers, professionals, and students, the journal not only fosters a deeper insight into toxicology, pharmacodynamics, and therapeutic strategies but also encourages innovation through its comprehensive access to groundbreaking experimental methodologies. The journal continues to foster discourse and disseminate research that shapes the future of pharmacological science.
Canadian Journal of Pain-Revue Canadienne de la Douleur
Innovative Insights for Effective Pain AlleviationCanadian Journal of Pain-Revue Canadienne de la Douleur is a premier, open-access journal published by Taylor & Francis Ltd, focusing on critical advancements in the field of pain management and anesthesiology. Since its inception as an open-access outlet in 2017, this journal has made significant strides in disseminating high-quality research and clinical findings, catering to a diverse audience of researchers, healthcare professionals, and students. With an impressive Q2 ranking in the fields of Anesthesiology and Pain Medicine, and a robust Scopus rank of 48 out of 136, the journal plays a vital role in enhancing knowledge, sharing innovative treatment modalities, and influencing best practices in pain alleviation. The journal’s commitment to accessibility has further solidified its position as a crucial resource in pain research, inviting contributions that aim to address the multifaceted challenges associated with pain management globally. Readers can find a wealth of invaluable peer-reviewed articles, reviews, and commentaries that support continued learning and collaboration within the field.
Pain Reports
Elevating the discourse in pain management and treatment.Pain Reports, published by LIPPINCOTT WILLIAMS & WILKINS, is a premier open access journal dedicated to advancing the field of anesthesiology and pain medicine. With an impressive impact factor and a ranking of #15 out of 136 in its category, this journal is recognized within the 89th percentile of its field as of 2023. Since its launch in 2016, Pain Reports has provided a vital platform for researchers, clinicians, and professionals to disseminate and access high-quality research articles, reviews, and case studies focused on the multifaceted aspects of pain management and treatment. Through its commitment to open access, the journal ensures that cutting-edge findings are readily available to a global audience, facilitating collaboration and knowledge sharing. With its scope continually evolving until 2024, Pain Reports strives to address the critical and emerging challenges in pain research, making it an essential resource for individuals dedicated to improving patient outcomes and advancing scholarly discourse in pain management.
PAIN
Unraveling the Complexities of PainPAIN is a renowned academic journal published by Lippincott Williams & Wilkins, specializing in the critical fields of *Anesthesiology* and *Pain Medicine*, as well as *Neurology* and *Pharmacology*. With an ISSN of 0304-3959 and an E-ISSN of 1872-6623, this influential journal has established itself as a premier platform for disseminating key findings and advancements in pain research since its inception in 1975. Recognized for its high impact factor, PAIN holds a commendable Q1 ranking across multiple categories, including a ranking of #3 out of 136 in *Anesthesiology and Pain Medicine,* which showcases its pivotal role in the scientific community. The journal’s comprehensive scope encompasses empirical studies, reviews, and clinical insights, making it indispensable for researchers, clinicians, and students dedicated to understanding and treating pain. Although currently not offering open access, PAIN ensures that readers have access to cutting-edge research backed by rigorous peer-review processes. Join a vibrant community of professionals committed to enhancing the management of pain and advancing neuroscience by engaging with the invaluable resources provided by PAIN.